Drug Profile
Factor VIII biosimilar - Axxo
Latest Information Update: 19 Nov 2021
Price :
$50
*
At a glance
- Originator AXXO
- Class Antihaemorrhagics; Blood coagulation factors; Recombinant proteins
- Mechanism of Action Blood coagulation factor replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Haemophilia
Most Recent Events
- 17 Sep 2013 Investigation for Haemophilia in Germany (Parenteral)